申请人:Kemijski Institut
公开号:EP3811940A1
公开(公告)日:2021-04-28
The present invention relates to substituted 4,5'-bithiazoles compounds as topoisomerase II catalytic inhibitors, and their use in therapy. In particular, the present invention relates to 4,5'-bithiazoles compounds of general formula (I) for use in therapy, particularly in the treatment of proliferative conditions, especially cancer. The present invention also relates to pharmaceutical compositions and combinations comprising 4,5'-bithiazoles compounds of general formula (I)
本发明涉及作为拓扑异构酶II催化抑制剂的取代4,5'-联噻唑化合物及其在治疗中的应用。特别是,本发明涉及通式(I)的4,5'-联噻唑化合物,用于治疗,特别是增殖性疾病,尤其是癌症的治疗。本发明还涉及包含通式(I)的 4,5'-联噻唑化合物的药物组合物和组合物